Thyroid-associated Orbitopathy: Quantitative Evaluation of the Orbital Fat Volume and Edema Using IDEAL-FSE
Tài liệu tham khảo
Kendler, 1993, The initial clinical characteristics of Graves’ orbitopathy vary with age and sex, Arch Ophthalmol., 111, 197, 10.1001/archopht.1993.01090020051022
Kahaly, 2001, Imaging in thyroid-associated orbitopathy, Eur J Endocrinol., 145, 107, 10.1530/eje.0.1450107
Ohnishi, 1994, Extraocular muscles in Graves ophthalmopathy: Usefulness of T2 relaxation time measurements, Radiology, 190, 857, 10.1148/radiology.190.3.8115640
Kaichi, 2016, Orbital fat volumetry and water fraction measurements using T2-weighted FSE-IDEAL imaging in patients with thyroid-associated orbitopathy, AJNR Am J Neuroradiol., 37, 2123, 10.3174/ajnr.A4859
Feldon, 1985, Quantitative computed tomography of Graves’ ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy, Arch Ophthalmol., 103, 213, 10.1001/archopht.1985.01050020065021
Peyster, 1986, Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis, AJR Am J Roentgenol, 146, 459, 10.2214/ajr.146.3.459
Fang, 2013, CT features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy, Int J Ophthalmol., 6, 146
Nishida, 2002, Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy, Graefes Arch Clin Exp Ophthalmol., 240, 515, 10.1007/s00417-002-0498-3
Kvetny, 2006, Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis, Acta Ophthalmol Scand., 84, 419, 10.1111/j.1600-0420.2005.00617.x
Prummel, 2001, The usefulness of quantitative orbital magnetic resonance imaging in Graves’ ophthalmopathy, Clin Endocrinol (Oxf)., 54, 205, 10.1046/j.1365-2265.2001.01220.x
Mayer, 2005, Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease, Eur J Radiol., 56, 20, 10.1016/j.ejrad.2005.03.027
Comerci, 2013, Semiautomatic regional segmentation to measure orbital fat volumes in thyroid-associated ophthalmopathy. A validation study, Neuroradiol J., 26, 373, 10.1177/197140091302600402
Jiang, 2012, Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves’ ophthalmopathy for assessment of disease activity, Acta Radiol., 53, 87, 10.1258/ar.2011.110431
Hu, 2010, Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans, Obesity (Silver Spring), 18, 841, 10.1038/oby.2009.352
Takasu, 2012, Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) imaging of multiple myeloma: Initial clinical efficiency results, Eur Radiol., 22, 1114, 10.1007/s00330-011-2351-8
Bartalena, 2008, Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO, Eur J Endocrinol., 158, 273, 10.1530/EJE-07-0666
Winand, 1988, Original acquisition in the pathogenesis and the treatment of endocrine ophthalmopathy, Metab Pediatr Syst Ophthalmol., 11, 126
Kahaly, 1994, Plasma glycosaminoglycans in endocrine ophthalmopathy, J Endocrinol Invest., 17, 45, 10.1007/BF03344962
Tengroth, 1964, Histological studies of orbital tissues in a case of endocrine exophthalmos before and after remission, Acta Ophthalmol., 42, 588, 10.1111/j.1755-3768.1964.tb00907.x
Papageorgiou, 2012, Thyroid-associated periorbitopathy: Eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy, Arch Ophthalmol., 130, 319, 10.1001/archopthalmol.2011.1271
Nishida, 2001, MRI measurements of orbital tissues in dysthyroid ophthalmopathy, Graefes Arch Clin Exp Ophthalmol., 239, 824, 10.1007/s004170100352
Potgieser, 2015, Some studies on the natural history of Graves’ orbitopathy: Increase in orbital fat is a rather late phenomenon, Eur J Endocrinol., 173, 149, 10.1530/EJE-14-1140
Watanabe, 2015, Radioiodine-associated exacerbation of Graves’orbitopathy in the Japanese population: Randomized prospective study, J Clin Endocrinol Metab., 100, 2700, 10.1210/jc.2014-4542